In millions, except per share items | Aug-31-14 | Aug-31-13 | Aug-31-12 | Aug-31-11 | Aug-31-10 | Jul-22-10 | Aug-31-09 | Jul-22-09 |
| 10-K | 10-K | 10-K | 10-K/A | 10-K | 10-K | 10-K | 10-K |
Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | 0.0 | |
Cost of goods sold | 2.2 | 3.0 | 1.8 | 1.0 | 0.0 | | 0.0 | |
Gross profit | -2.2 | -3.0 | -1.8 | -1.0 | 0.0 | | 0.0 | |
Selling, general and administrative [+] | 0.4 | 0.5 | 0.2 | 0.1 | 0.0 | | 0.0 | |
Sales and marketing | | | | | | | 0.0 | |
General and administrative [+] | 0.4 | 0.5 | 0.2 | 0.1 | | | 0.0 | |
General and administrative expenses | 0.4 | 0.5 | 0.2 | 0.1 | | | | |
Professional fees | 0.7 | 0.6 | 0.2 | 0.1 | | | | |
Other selling, general and administrative | | | | | | | 0.0 | |
Other operating expenses | 1.1 | 1.7 | 0.7 | | 0.0 | | 0.0 | |
EBIT [+] | -3.6 | -5.2 | -2.8 | -1.5 | 0.0 | | 0.0 | |
EBIT growth | -30.6% | 86.0% | 81.1% | | | | | |
Interest expense | 0.6 | | | | | | | |
Interest expense | 0.6 | | | | | | | |
Other income (expense), net [+] | | 11.8 | | | -0.1 | | 0.0 | |
Gain (loss) on debt retirement | | 0.0 | | | | | | |
Gain (loss) on foreign currency transactions | 0.0 | 0.0 | 0.0 | | | | | |
Pre-tax income | -4.2 | 6.6 | -2.8 | -1.5 | -0.1 | | 0.0 | |
Income taxes | 0.5 | 2.8 | 0.0 | 0.0 | 0.0 | | 0.0 | |
Tax rate | | 42.2% | 0.0% | 0.0% | 0.0% | | 0.0% | |
Net income | -4.8 | 3.8 | -2.8 | -1.5 | -0.1 | | 0.0 | |
|
Basic EPS [+] | ($0.24) | $0.20 | ($0.33) | ($0.23) | $0.00 | | $0.00 | |
Growth | -220.7% | -160.7% | 46.7% | 22956.6% | 568.5% | | | |
Diluted EPS [+] | ($0.24) | $0.19 | ($0.33) | ($0.23) | $0.00 | | $0.00 | |
Growth | -229.7% | -156.5% | 46.7% | 22956.6% | 568.5% | | | |
|
Shares outstanding (basic) [+] | 19.6 | 18.9 | 8.5 | 6.9 | 65.2 | | 100.9 | |
Growth | 3.6% | 123.5% | 23.5% | -89.5% | -35.4% | | | |
Shares outstanding (diluted) [+] | 19.6 | 20.3 | 8.5 | 6.9 | 65.2 | | 100.9 | |
Growth | -3.6% | 140.2% | 23.5% | -89.5% | -35.4% | | | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |